JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2022-08-26 ms5000000174582530

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心血管;糖尿病
经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！

479 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2023-06-24 MedSci_007 来自吉林省

第一天投稿，第二天under review，第四天with editor。。。。

255 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2021-03-02 延光星辰

2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷

767 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2020-05-17 ugly

你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表:
454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor

fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor

1463 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2022-09-01 146f0b62m05暂无昵称

under review状态时间改变了三四次是怎么回事

345 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2024-01-16 ms8000001820221539 来自湖南省

审稿速度:1.0
偏重的研究方向：代谢内分泌
经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀

140 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2022-01-25 陈呦呦

审稿速度:2.0
偏重的研究方向：心血管
经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept
稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。
Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。

1344 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2024-03-27 ms8000000183026287 来自山东省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊

87 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2023-10-28 ms4000001768031770 来自广东省

为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊

164 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1241105, encodeId=c8d0124110569, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：记录一下，第一个SCI：5月10日投稿的，大约5天内就被under review被送审了。一个月后返回。修稿一个月后，两周就接受啦。审稿速度非常可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35e75613536, createdName=ms5000000174582530, createdTime=Fri Aug 26 09:43:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144472, encodeId=076121444e2ef, content=第一天投稿，第二天under review，第四天with editor。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230102/946f899161a14c3dbe77c26d05ba17d8/114975187bd54951beda40eaafd6f34e.jpg, createdBy=59ae5404963, createdName=MedSci_007, createdTime=Sat Jun 24 09:58:02 CST 2023, time=2023-06-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=944787, encodeId=ab53944e87d6, content=2020.09.22投稿，一审3个月，催稿问了下，说是前两个审稿人意见有分歧，所以邀请了第三个审稿人；返回大修2个月；2021.02.04再投，目前with editor了，希望能接收，祈祷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=767, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLFHmdHZlP01VibUiaSUygPr1vfgUOicNUzicicuib25U9FM5WbtwPBfX6diaZbduz72Vjf0KFc8TINLKKvA/132, createdBy=d1062255989, createdName=延光星辰, createdTime=Tue Mar 02 14:31:35 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591055, encodeId=f0f659105521, content=你好，你的结果怎么样了，with editor后呢fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , beContent=fangfang424 2020-02-08 10:12:00 发表: 454646258，您的结果出来了吗？我是1.15投的，1.24 under review, 2.7 with editor , objectType=tool_impact_factor, channel=null, level=null, likeNumber=1463, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Sun May 17 00:00:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242368, encodeId=b039124236808, content=under review状态时间改变了三四次是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dee85178705, createdName=146f0b62m05暂无昵称, createdTime=Thu Sep 01 00:25:10 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182073, encodeId=9c2d21820e320, content=审稿速度:1.0 偏重的研究方向：代谢内分泌 经验分享：1.9号投的稿，已经过去7天了，一直在with editor的状态。想请教各位大佬何时才会under review呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d4b8504046, createdName=ms8000001820221539, createdTime=Tue Jan 16 21:41:20 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1187926, encodeId=a5d4118e92666, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：记录一下第一篇SCI：10/30/2021Submitted, 12/07/2021Revise, 01/04/2022Revise manuscript submitted, 01/13/2022Revise, 01/24/2022Accept 稿件处理速度可以，投稿后很快就Under review了，意见回来是major revision,两个审稿人在领域内比较专业，提了一大堆意见，花了近一个月时间才修好稿件，提交后面又经历了两次小修，意见回的很快，最后接收。 Revise后提交稿件要求Supplementary文件上传公共数据库并在文中引用，Manuscript里不能带有Supplementary图表的信息。Revise给的时间是3个月，还是很充裕的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1344, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d5e05514512, createdName=陈呦呦, createdTime=Tue Jan 25 08:40:28 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195585, encodeId=5f702195585d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月18日投稿，到现在一直是 Manuscript Submitted！什么情况，我看着大家的速度都挺快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7b725453206, createdName=ms8000000183026287, createdTime=Wed Mar 27 06:41:54 CST 2024, time=2024-03-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165427, encodeId=86f3216542ea7, content=为什么回顾性研究也邮件让我发provide the Institutional Review Board or ethical review board’s approval/exemption letter，我明明文章中已经提到which waived the requirement for informed consent because of the retrospective nature of this study啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e43b5476402, createdName=ms4000001768031770, createdTime=Sat Oct 28 16:07:09 CST 2023, time=2023-10-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113830, encodeId=447d211383008, content=杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b768120791, createdName=ms5000001832364730, createdTime=Thu Feb 09 18:28:27 CST 2023, time=2023-02-09, status=1, ipAttribution=山东省)]

2023-02-09 ms5000001832364730 来自山东省

杂志对格式要求很严格，必须机构邮箱投稿。投稿一篇，中途改格式和邮箱浪费了10多天，然后2天后被拒。

202 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务